Literature DB >> 7597445

Hepatitis C and hepatocellular carcinoma.

A M Di Bisceglie1.   

Abstract

Sufficient evidence has accumulated that chronic infection with HCV substantially increases the risk of HCC, particularly in the presence of cirrhosis. HCV appears to represent a major underlying cause of HCC in southern Europe and Japan, regions where HCC incidence is intermediate, whereas its impact is smaller in sub-Saharan Africa and China, where HBV-related HCC predominates, and in the developed western world, where the majority of cases of HCC are associated with cirrhosis of unknown etiology.

Entities:  

Mesh:

Year:  1995        PMID: 7597445     DOI: 10.1055/s-2007-1007263

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  31 in total

Review 1.  Treatment of recurrent hepatitis C following liver transplantation.

Authors:  T Bizollon; C Ducerf; J Baulieux; C Trepo
Journal:  Curr Gastroenterol Rep       Date:  1999 Feb-Mar

2.  Shear-wave elastography for the estimation of liver fibrosis in chronic liver disease: determining accuracy and ideal site for measurement.

Authors:  Anthony E Samir; Manish Dhyani; Abhinav Vij; Atul K Bhan; Elkan F Halpern; Jorge Méndez-Navarro; Kathleen E Corey; Raymond T Chung
Journal:  Radiology       Date:  2014-11-13       Impact factor: 11.105

3.  Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus: a 2.2 A resolution structure in a hexagonal crystal form.

Authors:  Y Yan; Y Li; S Munshi; V Sardana; J L Cole; M Sardana; C Steinkuehler; L Tomei; R De Francesco; L C Kuo; Z Chen
Journal:  Protein Sci       Date:  1998-04       Impact factor: 6.725

4.  Effect of previous interferon treatment on outcome after curative treatment for hepatitis C virus-related hepatocellular carcinoma.

Authors:  Hirokazu Miyatake; Yoshiyuki Kobayashi; Yoshiaki Iwasaki; Shin-Ichiro Nakamura; Hideki Ohnishi; Kenji Kuwaki; Junichi Toshimori; Hiroaki Hagihara; Kazuhiro Nouso; Kazuhide Yamamoto
Journal:  Dig Dis Sci       Date:  2011-10-12       Impact factor: 3.199

5.  Validation of Shear Wave Elastography Cutoff Values on the Supersonic Aixplorer for Practical Clinical Use in Liver Fibrosis Staging.

Authors:  Manish Dhyani; Joseph R Grajo; Atul K Bhan; Kathleen Corey; Raymond Chung; Anthony E Samir
Journal:  Ultrasound Med Biol       Date:  2017-03-22       Impact factor: 2.998

6.  Current management of hepatocellular cancer.

Authors:  Bernardino Rampone; Beniamino Schiavone; Giuseppe Confuorto
Journal:  Curr Oncol Rep       Date:  2010-05       Impact factor: 5.075

7.  An analysis of 412 cases of hepatocellular carcinoma at a Western center.

Authors:  Y Fong; R L Sun; W Jarnagin; L H Blumgart
Journal:  Ann Surg       Date:  1999-06       Impact factor: 12.969

Review 8.  Glypican-3 and alphafetoprotein as diagnostic tests for hepatocellular carcinoma.

Authors:  Jorge Filmus; Mariana Capurro
Journal:  Mol Diagn       Date:  2004

9.  Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradation.

Authors:  Irene S Ludwig; Annemarie N Lekkerkerker; Erik Depla; Fons Bosman; René J P Musters; Stany Depraetere; Yvette van Kooyk; Teunis B H Geijtenbeek
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

10.  Nerve growth factor involvement in liver cirrhosis and hepatocellular carcinoma.

Authors:  Guido Rasi; Annalucia Serafino; Lia Bellis; Maria Teresa Lonardo; Federica Andreola; Manuela Zonfrillo; Giovanni Vennarecci; Pasquale Pierimarchi; Paola Sinibaldi Vallebona; Giuseppe Maria Ettorre; Eugenio Santoro; Claudio Puoti
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.